New Drug Shows Promise Against Tough-to-Manage Asthma

THURSDAY, May 13, 2021 (HealthDay News) -- An experimental injectable drug appears more versatile than existing medications in treating people with different forms of severe, hard-to-control asthma, clinical trial results show.

There are many different types of asthma brought on by many different triggers, and a number of monoclonal antibody medications — called "biologics" — have been crafted to target distinct asthma triggers.